Alpha Healthcare Acquisition Corp (AHAC)

Etorro trading 970x250

About Alpha Healthcare Acquisition Corp

Alpha Healthcare Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York. Address: 1177 Avenue of The Americas, New York, NY, United States, 10036

Alpha Healthcare Acquisition Corp News and around…

Latest news about Alpha Healthcare Acquisition Corp (AHAC) common stock and company :

The Past Week's Notable Insider Buys: Callon Petroleum, Cricut, Krispy Kreme, And More
28 Aug, 2021 FinancialContent

With earnings-reporting season all but over, many insiders are free once more to buy or sell shares. Here are a few of the most noteworthy insider purchases that were reported in the past week.

The Past Week's Notable Insider Buys: Callon Petroleum, Cricut, Krispy Kreme And More
28 Aug, 2021 FinancialContent

Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Some ...

Humacyte Announces Successful Closing of Business Combination with Alpha Healthcare Acquisition Corp.
26 Aug, 2021 FinancialContent
Alpha Healthcare Acquisition Corp. Announces Shareholder Approval of Business Combination with Humacyte
24 Aug, 2021 FinancialContent
Humacyte Highlights Robust Expanded Access Program and Patient Testimonial for Human Acellular Vessels
19 Aug, 2021 FinancialContent
Humacyte Announces Addition of Chief Commercial Officer and Integration of Commercial-Scale Manufacturing into Clinical Trial Programs
17 Aug, 2021 FinancialContent
Alpha Healthcare and Humacyte Announce Nominees for Election to Post-Merger Public Company Board of Directors
13 Aug, 2021 FinancialContent
Humacyte Announces Publication of In Vivo Data on Biovascular Pancreas Transplantation for the Treatment of Type 1 Diabetes
11 Aug, 2021 FinancialContent
Alpha Healthcare Acquisition Corp. Sets August 24, 2021, for Special Shareholder Meeting to Vote on Humacyte Business Combination
04 Aug, 2021 FinancialContent
The Week In SPAC News - Sunday, July 25
25 Jul, 2021 FinancialContent

In SPAC news this week, BBQGuys, PropertyGuru, and Cvent announced merger deals, while Vice Media's plan to go public via a SPAC merger has reportedly stalled.

Humacyte Presents Potential of Functional Lung Engineering at Janelia R3 – Replace, Repair, Regenerate Planning Workshop
22 Jul, 2021 FinancialContent
Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2021
20 Jul, 2021 FinancialContent

Upgrades For Bank of Marin Bancorp (NASDAQ:BMRC), Keefe, Bruyette & Woods upgraded the previous rating of Market ...

UPDATE -- Humacyte Expands Strategic Global Partnership with Fresenius Medical Care
11 Jun, 2021 Yahoo! Finance

Partnership expanded to include vascular trauma repair outside of the United States.Fresenius Medical Care is a leading participant in fully committed PIPE financing transaction. DURHAM, N.C., June 11, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, announces the expansion of the strategic collaboration between Fresenius Medical Care, the world’s largest provider of dialysi

Humacyte Expands Strategic Global Partnership with Fresenius Medical Care
11 Jun, 2021 FinancialContent
Humacyte to Participate in Fireside Chat at Cowen 6th Annual FutureHealth Conference
10 Jun, 2021 FinancialContent
Humacyte Presents In Vivo Data on Biovascular Pancreas Transplantation for Type 1 Diabetes Treatment
08 Jun, 2021 FinancialContent
Humacyte to Provide Investor Update on June 7
04 Jun, 2021 FinancialContent
Humacyte to Provide Investor Update on June 7
04 Jun, 2021 Yahoo! Finance

DURHAM, N.C., June 04, 2021 (GLOBE NEWSWIRE) -- Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced an investor update presentation will be available at 9:00 a.m. ET on Monday, June 7 at http://www.humacyte.com/investor_update. The presentation will review the Company’s clinical programs and progress, as well as its scientific platform and current business plans. The presentation will b

Humacyte Receives 2021 Life Sciences Award from Triangle Business Journal
26 May, 2021 FinancialContent

Company recognized for its innovative contributions to the life sciences industry in North Carolina

EXCLUSIVE: Humacyte, Alpha Healthcare CEOs Talk SPAC Deal, Technology, Trials On 'SPACs Attack'
25 May, 2021 FinancialContent

Humacyteis set to go public via the special purpose acquisition companyAlpha Healthcare Acquisition Corp (NASDAQ: AHAC) in a ...

Humacyte Announces Presentation by Principal Investigator Highlighting Clinical Experience with HAVs at Vascular Access Society of the Americas 2021 Spring Conference
22 May, 2021 FinancialContent

HAV performance in the clinical setting as an arteriovenous reconstruction underscores the potential for use as vascular access conduits for dialysis patients

Humacyte Presents Advances in Whole-Lung Engineering
21 May, 2021 FinancialContent
Humacyte Appoints Dale Sander as Chief Financial Officer
19 May, 2021 FinancialContent

Proven CFO with extensive financial leadership and commercialization experience, including multiple publicly listed life sciences companies

What Is The Ownership Structure Like For Alpha Healthcare Acquisition Corp. (NASDAQ:AHAC)?
07 May, 2021 Yahoo! Finance

The big shareholder groups in Alpha Healthcare Acquisition Corp. ( NASDAQ:AHAC ) have power over the company. Large...

Humacyte Leadership and Investigators to Present at Five Scientific Events in May
06 May, 2021 FinancialContent
Humacyte Announces Positive Long-Term Follow-Up Data from Phase 2 Vascular Access Trial
21 Apr, 2021 FinancialContent
Humacyte Secures $50 Million Debt Facility with Silicon Valley Bank
14 Apr, 2021 FinancialContent
The 'Boiler Room' Stock Pitch Recap: Northern Star Acquisition, Mogo, WISeKey, AutoZone And More
09 Apr, 2021 FinancialContent

Every Friday, at 3 p.m. ET, Ritholtz Wealth Management CEO Josh Brown and Benzinga CEO Jason Raznick host "The Boiler Room," a ...

Benzinga's Top Ratings Upgrades, Downgrades For April 9, 2021
09 Apr, 2021 FinancialContent

Upgrades For Assertio Holdings Inc (NASDAQ:ASRT), Gabelli & Co. upgraded the previous rating of Hold to Buy. The ...

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Alpha Healthcare Acquisition Corp. - AHAC
27 Mar, 2021 Yahoo! Finance

Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Alpha Healthcare Acquisition Corp. ("AHAC" or the "Company") (AHAC) relating to its proposed merger with Humacyte, Inc. Under the terms of the agreement, AHAC will acquire Humacyte through a reverse merger, with Humacyte emerging as a publicly traded company.

Alpha Healthcare Acquisition Corp (AHAC) is a NASDAQ Common Stock listed in , ,

970x250